This application supports the career development of Brian Poligone, MD, PhD. who has an interest in the molecular signaling of NF-KB and its effect on the skin. The transcription factor NF-KB provides a regulatory on/off switch for gene expression that is important for inflammation and carcinogenesis. By understanding the role of NF-KB in the biology of keratinocytes and cutaneous lymphoid cells, inflammatory skin diseases and cancers may be better understood. We have constructed a novel mouse model to examine the NF-KB pathway in skin. The homozygous p65 S276D (PD) knock-in mouse contains a mutant form of NF-KB that increases the basal transcriptional activation of NF-KB dependent genes. Because studies on NF-KB activity in the skin have been underrepresented, detailed examination of the PD mouse should help clarify this central mediator of inflammation and tumorigenesis. Transcription factors are proteins that are the main on/off switch in regulating gene expression. NF-KB is a transcription factor that is known to be a central regulator of both inflammatory and oncogenic processes. Studying NF-KB in genetically engineered mouse models helps to clarify the role of NF-KB and allows a better understanding of its activity in inflammatory disease and cancer and ultimately may lead to improved patient care.

Public Health Relevance

By understanding the basic mechanisms that lead to both skin inflammation and tumorigenesis, better treatments for skin disease are possible. It is through this basic understanding of skin disease that better treatments of can be identified.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Clinical Investigator Award (CIA) (K08)
Project #
Application #
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Cibotti, Ricardo
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Rochester
Schools of Dentistry
United States
Zip Code
Chen, Luojing; Hayden, Matthew S; Gilmore, Elaine S et al. (2018) PKK deletion in basal keratinocytes promotes tumorigenesis after chemical carcinogenesis. Carcinogenesis 39:418-428
Chung, Catherine G; Poligone, Brian (2015) Other Chemotherapeutic Agents in Cutaneous T-Cell Lymphoma. Dermatol Clin 33:787-805
Poligone, B (2015) Risk of mortality in hydroa vacciniforme and hypersensitivity to mosquito bites. Br J Dermatol 172:5-6
Poligone, Brian; Gilmore, Elaine S; Alexander, Carolina V et al. (2015) PKK suppresses tumor growth and is decreased in squamous cell carcinoma of the skin. J Invest Dermatol 135:869-876
Chung, Catherine G; Poligone, Brian (2015) Cutaneous T cell Lymphoma: an Update on Pathogenesis and Systemic Therapy. Curr Hematol Malig Rep 10:468-76
Poligone, Brian (2014) The good, the bad, and the ugly of free drug samples. JAMA Dermatol 150:1237-8
Ladrigan, Manasi Kadam; Poligone, Brian (2014) The spectrum of pigmented purpuric dermatosis and mycosis fungoides: atypical T-cell dyscrasia. Cutis 94:297-300
Wahrendorf, Morten; Reinhardt, Jan D; Siegrist, Johannes (2013) Relationships of disability with age among adults aged 50 to 85: evidence from the United States, England and continental europe. PLoS One 8:e71893
Poligone, Brian; Hayden, Matthew S; Chen, Luojing et al. (2013) A role for NF-?B activity in skin hyperplasia and the development of keratoacanthomata in mice. PLoS One 8:e71887
Poligone, Brian; Heald, Peter (2012) Menus for managing patients with cutaneous T-cell lymphoma. Semin Cutan Med Surg 31:25-32

Showing the most recent 10 out of 12 publications